BioGenerator

About The Fund

BioGenerator is a prominent investment firm based in St. Louis, Missouri, specializing in the creation, growth, and investment of promising health and plant sciences companies. The firm operates as the investment arm of BioSTL and plays a critical role across the startup lifecycle, concentrating on therapeutic, diagnostic, medical device, agricultural, and healthcare sectors. BioGenerator delivers value to its portfolio companies through a unique blend of expertise in debt and equity investment and specialization in seed, startup, early-stage ventures. As a startup studio, its strategic approach includes identifying and de-risking commercially attractive innovations, providing rigorous advisory services, and recruiting entrepreneurial talent. BioGenerator's investment model is characterized by staged and due-diluted investments, underpinned by comprehensive due diligence. Companies benefit from BioGenerator's significant infrastructure support, which includes access to specialized lab spaces and capital equipment. Additionally, BioGenerator fosters company growth by offering access to BioGenerator Labs, which aggregate technology, talent, proof of concept grants, coaching, and lab space, accelerating new ventures. Their investment portfolio showcases over 50 active investments and a track record of leveraging the initial capital invested, boasting a $39 million investment into startups resulting in over $2.6 billion raised by its companies. Case studies on their website highlight the intersection of investment capital with company-building resources, demonstrating a significant impact on the companies' successes. Supporting startups goes beyond financing as they provide essential tools such as talent acquisition, investor relations, and strategic grant trainings. BioGenerator emphasizes the value of its network, instrumental in launching companies, and securing further investments, thereby sustaining St. Louis as a thriving hub for innovation in health and plant sciences.